financetom
Market
financetom
/
Market
/
Freeport-McMoRan Scores A Solid Q3, Analysts Say: 'Benefit From High Copper And Gold Prices'
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Freeport-McMoRan Scores A Solid Q3, Analysts Say: 'Benefit From High Copper And Gold Prices'
Oct 27, 2024 6:10 AM

Freeport-McMoRan ( FCX ) closed Wednesday’s trading session 1.26% lower at $47.92 as the market further digested its third-quarter earnings results.

The leading copper miner reported slightly lower earnings per share, coming at $0.36 instead of the expected $0.37, while soundly beating the consensus revenue estimates of $6.44b, with an actual $6.79.

The response from institutions has been mixed.

Raymond James raised the price target to $57 from $55, maintaining an Outperform rating.

RBC Capital Markets maintained a Sector Perform rating with a price target of $58.

Scotiabank maintained a Sector Perform rating with a price target of $52.

Raymond James analyst Brian MacArthur issued an optimistic view on the miner, quoting sales of 1 billion lbs of copper and 550 Koz of gold in Q3. He noted management’s expectations to reach 4.1 billion lbs and 1.8 Moz of gold for 2024 and a cash cost of $1.58 per lb of copper.

Meanwhile, the RBC Capital Market highlighted strong free cash flow (FCF), driven by higher copper and gold prices. The firm estimates Freeport can generate $4.8 billion in FCF for 2025, yielding a 7% return at current spot prices.

“Freeport continues to benefit from high copper and gold prices,” RBC noted, emphasizing the company's significant leverage to these metals, particularly with copper comprising 75% of its revenue.

While acknowledging strong financials, RBC noted some near-term risks related to Freeport’s Indonesian smelter, which suffered a fire in October. This could delay production ramp-up into 2025. Furthermore, the smelter issue could require an extension of Freeport’s concentrate export permit, which expires at the end of the year.

While RBC projects a price target of $58, the potential upside scenario goes as high as $80.

Scotiabank’s reaction to Freeport-McMoRan's ( FCX ) Q3 2024 earnings was neutral, though it recognized the company’s stronger-than-expected performance. Scotiabank's estimate was lower than the market consensus, at $0.30.

Despite the positive earnings, Scotiabank maintained its “Sector Perform” rating on FCX, highlighting a “relatively balanced risk-reward” profile, but slightly reduced its 12-month price target from $52 to $52.

Analyst Orest Wowkodaw noted that the multi-year production guidance remained unchanged, with copper cash cost guidance in line with prior expectations. Scotiabank pointed out that the multi-year production guidance remained unchanged, with copper cash cost guidance in line with prior expectations.

It is worth noting that Wowkodaw downgraded Freeport-McMoRan ( FCX ) to Sector Perform from Outperform on September 30, citing recent share price appreciation and the negligible implied return to its target for the downgrade after its shares rose 28% through September.

Read Next:

Lithium Reserve Found In Arkansas With Help From AI: Why It Impacts Exxon Mobil

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Ampio Pharmaceuticals Takes Voluntary Decision to Delist From NYSE American; Shares Plunge Premarket
Ampio Pharmaceuticals Takes Voluntary Decision to Delist From NYSE American; Shares Plunge Premarket
Mar 26, 2024
06:39 AM EDT, 03/26/2024 (MT Newswires) -- Ampio Pharmaceuticals ( AMPE ) said late on Monday that its board voluntarily decided to delist its common stock from the NYSE American. The company said the board based its decision on factors such as the current and likely future non-compliance with listing requirements that would inevitably result in delisting. The board also...
Design Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying
Design Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying
Mar 26, 2024
The Dow Jones index closed lower by over 150 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny...
US STOCKS-Futures rise as megacap, chip stocks bounce
US STOCKS-Futures rise as megacap, chip stocks bounce
Mar 26, 2024
(For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window.) * Futures up: Dow 0.20%, S&P 0.34%, Nasdaq 0.49% March 26 (Reuters) - U.S. stock index futures ticked up on Tuesday as most megacap and chip stocks advanced, while investors readied for more data to assess the Federal Reserve's rate...
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Tuesday Ahead of Durable Goods, Consumer Confidence Data
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Tuesday Ahead of Durable Goods, Consumer Confidence Data
Mar 26, 2024
08:17 AM EDT, 03/26/2024 (MT Newswires) -- The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.4% and the actively traded Invesco QQQ Trust (QQQ) was 0.5% higher in Tuesday's premarket activity ahead of the US durable goods and consumer confidence data slated for release later. US stock futures were higher, with S&P 500 futures up...
Copyright 2023-2025 - www.financetom.com All Rights Reserved